Our Team

Thomas Christenson is a financial executive with more than 30 years of experience in professional skincare and life sciences, with a track record spanning growth leadership, operational execution, and complex financial transactions including M&A, IPOs, venture and private equity raises, venture debt, and business development.

Prior to becoming the CFO of Rapalogix Health, he served as CFO of Alastin Skincare from 2016 through April 2024, where he helped build one of the most recognized names in physician-dispensed skincare. Under his financial leadership, Alastin was consistently recognized as the fastest-growing company in the professional skincare channel, earning awards for growth, best startup, and San Diego's top workplace. In December 2021, Alastin was acquired by Galderma at a valuation exceeding the top of the comparable range.